Week in review: Yahoo's bitter pill for Icahn
Yahoo's poison pill may keep Yang with the company. Icahn sets a price and sets out his terms. Meanwhile, we await what's up Steve Jobs' sleeve. Also: Green tech.
Tags : news newscom-miscellaneous
You will be redirected to Week in review: Yahoo's bitter pill for Icahn, in 20 seconds.
